Comparison Overview
Pall Medical, part of Cytiva
Pall Medical, part of Cytiva
undefined, Global, undefined, undefined, US
Last Update: 04/01/2026
We are an innovative Healthcare provider for Medical Filtration solutions. Our team of experts can support with unique and cost effective solutions within a variety of Medical Healthcare industries: Infusion Therapy, OEM Media & Membrane, Water Filtration, Mechanical Ve...
Boston Scientific
100 Boston Scientific Way, Marlborough, 01752, US
Last Update: 01/04/2026
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solu...
Compliance Ranges Comparison
Pall Medical, part of Cytiva
Boston Scientific
Benchmark & Cyber Underwriting Signals
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
No incidents recorded for Pall Medical, part of Cytiva in 2026.
Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)
Boston Scientific has 3.85% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - Pall Medical, part of Cytiva (X = Date, Y = Severity)
Pall Medical, part of Cytiva cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Boston Scientific (X = Date, Y = Severity)
Boston Scientific cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Pall Medical, part of Cytiva
Boston Scientific
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.